stitute an independent and significant risk factor for cardiovascular diseases (3). In addition, elevated levels of homocysteine and low maternal levels of BIZ are correlated with neural tube defects (4,5). Methionine synthase is thus an important housekeeping enzyme at the intersection of sulfur and one-carbon metabolism, and its regulation influences intracellular homocysteine and folate pools. The consequences of lowering homocysteine with vitamins are being measured in clinical intervention studies. Thus, elucidating the mechanism by which BIZ induces methionine synthase activity and thereby affects homocysteine pools may have an important bearing on these intervention studies.
Studies by Mangum and North almost thirty years ago on the regulation of mammalian methionine synthase in HEp-2 cells in culture revealed that supplementation of the medium with BIZ resulted in a thirtyfold elevation of enzyme activity (6) . This was later extended to several other cell lines in which the BIZinduced activation of methionine synthase ranged from 10-to 30-fold (7) . In the initial experiments, homocgsteine and vitamin BIZ replaced methionine and choline in the medium. Homocysteine was however found to have no effect on the activation of methionine synthase, since BIZ in the presence or absence of homocysteine yielded the same extent of stimulation (7) . The activity of the only other mammalian BIZ-dependent enzyme, methylmalonyl-CoA mutase, was unchanged upon supplementation of the medium with BIZ (8) .
Several alternative hypotheses can be considered to explain induction of methionine synthase activity by its cofactor, BIZ. First, if intracellular BIZ concentration is limiting, increase in enzyme activity could be due to conversion of apoenzyme to holoenzyme. Second, BIZ may exert its regulation at the methionine synthase promoter resulting in increased transcription. Third, BIZ may enhance translation of the methionine synthase mRNA, either by affecting the stability of the message or by increasing access of the message to the translation apparatus. Fourth, B1, may enhance the stability of methionine synthase thereby affecting its turnover in the cell. Finally, B,, may induce one or more genes that in turn increases the level of methionine synthase either at a transcriptional or posttranscriptional level.
The recent cloning of the human methionine synthase cDNA (9-11) and the development of sensitive assays to measure the relative apo-and holoenzyme content of the enzyme (12-14) now permit evaluation of these alternative hypotheses. In this study, we have examined whether the induction of methionine synthase by B,, is correlated with changes in the mRNA levels, protein levels or the percent holoenzyme. Our studies clearly point to a post-transcriptional mechanism of activation of methionine synthase that is dependent on the synthesis of new enzyme.
MATERIALS AND METHODS
Materials. EMEM and hydroxocobalamin were purchased from Sigma. Fetal calf serum was from Calbiochem. The RNeasy kit was from Qiagen and Hybond N+ membrane was from Amersham. RNase free reagents (MOPS, SSC) were molecular biology grade and were purchased from 5 Prime-3 Prime. DEPC treated water was used for making up solutions for RNA studies. Cell lines, Cos-7 (SV4O-transformed African Green Monkey kidney cells), HeLa (human cervical carcinoma cells), HepG2 (human hepatoblastoma cells), and 293 (transformed human kidney cells) cells were from ATCC, and 293 t' (derivative of 293 expressing the T antigen) was from Mike Fudos (NIH). The actin probe was from an in vitro transcription kit from Ambion.
Cell culture. Cells were cultured in EMEM supplemented with 10% fetal bovine serum and maintained a t 37"C, 5% CO,. The concentration of folic acid and methionine in this medium are 2.3 pM and 100 pM respectively. The estimated concentration of BIZ in the unsupplemented medium is -125 pM, and is derived from the serum (15) . For studies involving RNA isolation, confluent cells from 4 or 5 petri dishes (150 mm) were harvested and frozen in lysis solution and stored a t -80°C until further processing.
For studies involving protein analysis (enzyme assays or Western blots) cell monolayers were washed with PBS, collected by centrifugation and the pellet was washed twice with PBS prior to freezing a t -80°C. For B,, induction studies, cells were grown to subconfluency before replacement of the medium with fresh EMEM supplemented with OHBIZ a t a concentration of 5 mg/L. The BIZ concentration was chosen based on the dose response for methionine synthase activity that has been reported previously (15) . For experiments in which methionine synthase activity, and protein and RNA levels were being determined simultaneously a t fixed time points following BIZ addition (0, 24, and 48 h), a large number of plates were cultured in parallel. Cells from 3 or 4 petri dishes were used per time point for each of the protein and RNA determinations.
Methionine synthase assay using cell extracts. The cell extracts were prepared and anaerobic assays were performed essentially as described previously (13) . The cell extracts for the assays were thawed immediately prior to their use. They were made anaerobic by gently passing N, for 30 min over the extracts in 1.5 ml eppendorf tubes sealed with red rubber septa. The amount of protein used in the assays ranged from 0.3 mg to 0.6 mg. Protein concentrations were determined using the Bradford assay (BioRad) with bovine serum albumin as standard. One unit of activity is defined as the amount of protein required to synthesize one pmol of methionine h-' a t 37°C. RNA isolation. RNA was isolated using the RNeasy kit as per the vendor's protocol (Qiagen). Aliquots (20-30 pl) of RNA were stored a t -80°C until needed.
Northern analysis. RNA samples (10-15 pg) were heated a t 65°C for 5 min and then cooled immediately on ice prior to loading onto a 1% formaldehyde agarose gel. The gel was electrophoresed in RNase free 1X MOPS (25 volts for -20 h a t 4"C), equilibrated with 10X SSC and transferred to a Hybond N+ membrane in the same buffer. After overnight transfer, RNA was UV-linked to the membrane. Prehybridization and hybridizations were performed in Church and Gilbert hybridization buffer. Hybridization was conducted overnight a t 65°C for 12 h (with 3 x lo6 dpm per ml radiolabeled probe). An NcoI-EcoRI fragment containing the homocysteine-binding domain in plasmid SGHcy-28a (described below) was used as one of the probes. Probes (for methionine synthase and actin) were radiolabeled with 32P (Rediprime kit from Amersham Life Science). Following hybridization, the membrane was washed a t 65°C for 3 x 20 min with 2X SSC and 0.1% SDS. The membrane was exposed to a phosphoimager screen for 2-3 days a t room temperature and then scanned.
Cloning and expression of homocysteine binding domain of human MS. The N-terminal region of human methionine synthase extending from amino acids 1 to 368 is homologous to the homocysteine binding domain of the E. coli protein ranging from residues 2-353 (16, 17) . The segment of the human cDNA encoding this fragment was amplified by PCR and cloned using the primers described below. An NcoI site and an EcoRI site were engineered into the 5' sense and 3' antisense primers respectively and are indicated in bold letters in the primer sequences shown below. 5' sense: 5' CATGCCAXGG-CTCCGGCGCTGCAGGACCTGTCGC 3'. 3' antisense: 5' GAATTCAATGlTAACAAAlTACTAGTACGGTCCAATCCT 3'. In the 5' primer, the E. coli codon preference was employed at some locations to potentially enhance translation efficiency. The codon preference for amino acids following the initiator methionine codon located within the NcoI site (underlined in primer sequence) are indicated in parentheses: Met-Ala (E. coli)-Pro (E. co1i)-Ala (human)-Leu (E. co1i)-Gln (E. co1i)-Asp (human)-Leu (human)-Ser (human). In the 3' primer, two tandem stop codons (underlined) were engineered into the sequence after residue 368 encoding tyrosine. A 1.1 kb fragment was amplified by PCR using Klentaq polymerase (Clonetech) and cDNA from human pancreas (Clonetech) as template. The amplified band was initially cloned into the TA vector, PCR 2.1, from Invitrogen, and the ligation mixture was used to transform E. coli Top10 F' cells (Invitrogen). DNA from a single colony was digested with NcoI and EcoRI and the fragment was cloned into the pet 28 a expression vector (Novagen) to create SGHcy-28a, and transformed into BL21 DE3. The DNA sequence of the insert in SGHcy-28a was determined.
Expression of homocysteine binding domain of human methionine synthase. A colony containing plasmid SGHcy-28a with the 1.1 kb insert, was grown overnight in 2 ml LB medium (containing 50 pglml kanamycin) which was used to inoculate a 50 ml LBkanamycin culture the next day. The culture was grown a t 37°C to an O.D,,, of 0.5-0.6 (-3 h) and expression was induced with 0.8 mM IPTG for 3 h. Cells were collected by centrifugation and the pellet was resuspended in 3 ml of 50 mM Tris-HC1 pH 8.0,2 mM EDTA. The soluble and insoluble cell fractions were obtained using a protocol from Novagen. Lysozyme a t a concentration of 100 pglml and 0.1 volume of 1% Triton X-100 (Bio-Rad) were added to the resuspended pellet and incubated a t 30°C for 15 min. This was followed by centrifugation at 12,000 X g for 15 min a t 4°C. The soluble (supernatant) and insoluble (pellet) fractions were resuspended in a 1X SDS sample loading buffer (Bio-Rad) containing P-mercaptoethanol, and separated by electrophoreses on a 10% SDS polyacrylamide gel ( Figure  3A ). The identity of the recombinant 37 kDa band was confirmed by N-terminal amino acid sequence analysis and by Western analysis using antibodies generated against porcine methionine synthase (12). DNA and N-terminal sequence analyses revealed that Glu 12 " Specific activity is expressed in pmol methionine formed min-' mg-' a t 37°C. The fold increase was estimated by comparing the values for specific activities measured in the presence of added BIZ.
was deleted. This could have resulted from a polymorphism a t this position that was present in the cDNA library or, more likely, from a PCR error.
Generation of antibodies against the human methionine synthase. The pellet containing the insoluble N-terminal domain of human methionine synthase was washed extensively with 50 mM Tris, pH 8.0 containing 2 mM EDTA. The washed pellet (-1.5 mg) was separated on a preparative 7% SDS polyacrylamide gel and the band of interest was excised after staining with Coommasie brilliant blue R-250 (Bio-Rad) followed by extensive destaining. The excised band was sent to a commercial antibody facility (Alpha Diagnostics, Texas) for generation of polyclonal antibodies in rabbits.
Western analysis of human methionine synthase in cells cultured in medium ? B,,. Extracts (50 bg protein), from cells grown in EMEM medium supplemented with B,, for 0.24 and 48 h. were separated on a 5% SDS ~olyacrylamide geir The 'proteins were transferred to a PVDF membranes using a tank electroblotter for 6 h a t 100 V. Western analysis was performed using a 1:100 dilution of the first antibody and a 1:5000 dilution of the second antibody, anti-rabbit IgGIalkaline phosphatase conjugate (BioRad), followed by chemiluminescent detection using the CDP-Starr kit (Tropix). Chemiluminescent signals were quantitated using a Molecular Dynamics densitometer.
RESULTS
Induction of methionine synthase activity by Biz is not due to apoenzyme to holoenzyme conversion. In order to examine whether or not activation by B,, is due to conversion of apoenzyme to holoenzyme, the effect of B,, addition to the cell culture medium was examined in five different cell lines (Table I) . Enzyme activity was measured in the anaerobic titanium citrate assay either in the presence or absence of exogenous B,,. Activity determined in the presence of B12 represents total methionine synthase activity. In the absence of B,,, only holoenzyme activity is measured.
Thus the ratio of activity observed in the absence to that in the presence of additional cofactor represents the proportion of holoenzyme present. As shown in Table I , all five cells lines showed stimulation of methionine synthase activity when the medium was supplemented with B,,. The fold increase varied with the cell line, ranging from 2-fold in HeLa cells to -14-fold in HepG2 cells. Increasing the concentration of the cofactor ten-fold did not further increase the foldinduction (data not shown). Comparison of enzyme activity from cells that had been supplemented with B,, with those grown in unsupplemented media show that the proportion of holoenzyme remained the same, within experimental error. The only exception was 293t' cells where the holoenzyme content increased from 34% to 100%. However, the 3-fold increase in percent holoenzyme does not account for the almost 6-fold increase in methionine synthase activity resulting from B,, supplementation. 293 cells were employed for the remainder of the studies described below because of their high holoenzyme content and rapid growth rate.
Kinetics of methionine synthase induction by B,,. The time course for the activation of methionine synthase was examined next. As shown in Figure 1 , increase in methionine synthase activity could be observed as early as two hours following B,, addition. The activity increased rapidly during the first six hours reaching a plateau in -24 to 48 h and was sustained until 72 h. B,, supplementation does not change methionine synthase RNA levels. To examine whether the B,, effect is due to transcriptional activation of the methionine synthase gene, mRNA levels were analyzed 0, 24 and 48 h after addition of the cofactor (Figure 2A ). Two methionine synthase mRNA's of -10 and 7.5 kb sizes were observed by Northern analysis as has been reported previously (9,ll). However, the level of methionine synthase mRNA remained unchanged during the same period that a 2.5-fold increase in enzyme activity was observed. Equal loading of RNA in the three lanes was confirmed by probing for the actin message ( Figure  2B ). Northern analysis of three other cell lines (COST, HepG2 and 293t') also revealed that the methionine synthase mRNA levels do not change upon B,, supplementation (data not shown). 
FIG. 1. Kinetics of methionine synthase induction in 293 cells by
B,,. cells were grown to subconfluency in 150 mm petridishes as number of nutrients function as cofactors or substrates a t described under Materials and Methods. The medium was aspirated the homocysteine metabolic junction. Cystathionine off and replaced with fresh EMEM with either ? B,,. The cells were P+,pthase is a vitamin B,-and heme-dependent enzyme harvested by scraping at the indicated time points and frozen until whereas met.onine synthase requires both B,, and a further analysis. Methionine synthase activity was determined in the anaerobic titanium citrate assay in the absence of additional folate derivative, CH,-H,folate, for activity. This has recobalamin. The time points were repeated in either duplicate or cently led to the promotion of a multivitamin tablet contriplicate, and standard errors are indicated.
taining B,, BIZ, and folic acid as a '%omocysteine defense" Western analysis of methionine synthase levels in cell cultures exposed to B,,. Cell extracts from the 0, 24 and 48 h time points were analyzed by Western blotting. As shown in Figure 3B , an increase in methionine synthase level is observed between the 0 and 24 h time points, while the difference between the 24 and 48 h time points is negligible. To ensure equal loading, the membrane was also exposed to antibody generated against the P. shermanii methylmalonyl-CoA mutase. As expected, the levels of this protein did not exhibit a time dependent change ( Figure 3B lower panel) . An additional lower band also crossreacted with the mutase antibody. Although its identity is unknown (it may be a proteolytic form), it serves as an additional control to demonstrate that a specific increase in methionine synthase levels is observed on supplementation of the medium with B,,.
DISCUSSION

B
Elevated concentrations of homocysteine are correlated with risk for two apparently unrelated pathologies: cardiovascular diseases (3) and neural tube defects (5). In mammalian cells, two major enzymatic routes detoxify homocysteine. Transmethylation, catalyzed by either methionine synthase or betaine homocysteine methyltransferase, salvages homocysteine to the AdoMet-dependent methylation cycle. Transsulfuration, catalyzed by cystathionine P-synthase converts homocysteine to cystathionine, and represents the first step in its catabolic removal. Due to the limited tissue distribution of betaine homocysteine methyltransferase in the liver and kidney (18), methionine synthase is the major transmethylase. A formula, and to folic acid fortification of flour in the U.S.
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in an effort to reduce the incidence of neural tube defects. Homocysteine lowering intervention studies using differ-
2.5
ent vitamin regimens are either imminent or ongoing in several countries.
Understanding the role of cofactors in regulating the .$ 2.0 j activities of enzymes at the homocysteine metabolic junction is therefore of importance from a clinical a .i 1.5 standpoint. One of these cofactors, B,,, was described 2 thirty years ago, to induce activity of methionine syn- 1 .o thase in cell culture (6) . In this study we have also observed that B,,-induces a 2 to 14-fold increase in methionine synthase activity in different cell lines. The 0.5 mechanism by which exogenous B,, in the cell culture medium causes an increase in methionine synthase activity was previously unknown, although it had been ascribed to conversion of preexisting apoenzyme to holoenzyme (8, 15) .
However, evaluation of the percent holomethionine synthase is complicated by its existence in multiple oxidation states, containing B,, as methylcob(II1)-alamin, hydroxycob(III)alalmin or cob(I1)alamin. Of these, only the first is active under i n vitro assay conditions, and then only, for a limited number of turnovers (100-2000 depending on the degree of anaerobiocity (19, 20) ). This results from the oxidative sensitivity of the cofactor intermediate, cob(I)alamin, under catalytic turnover conditions. The oxidized forms of the enzyme can be reactivated in the presence of a one electron donor and S-adenosylmethionine. The standard i n vitro assay employs dithiothreitol and OHB,, as a source of electrons. In the absence of OHB,,, dithiothreitol is unable to transfer electrons to methionine synthase (21) . The problem with this assay arises from its dependence on OHB,,, which serves both to transfer electrons from dithiothreitol to activate oxidized holoenzyme and binds to apoenzyme, eventually converting it to holoenzyme (12) . Thus, the complexity of the methionine synthase assay has resulted in significant underestimation of the holoenzyme content in the literature.
This problem is addressed by employing titanium citrate as the electron donor since it can directly reduce methionine synthase (12) . Under these assay conditions, the relative content of apo-and holoenzyme can be evaluated by measuring activity in the presence and absence of exogenous OHB,,. Using this assay, we demonstrate that the increase in methionine synthase activity is not correlated with conversion of apoenzyme to holoenzyme (Table I ). In fact in four of the five cell lines, addition of B,, to the cell culture medium does not affect the level of holomethionine synthase at all. One exception, 293t' cells, show a 3-fold increase in holoenzyme under these conditions, although this is insufficient to account for the 5.7-fold increase observed in methionine synthase activity. These results necessitate evaluation of alternative mechanisms to The recent cloning of the human methionine synthase cDNA permits direct evaluation of the mRNA levels as a function of time following exposure to B,,. In order to choose appropriate time points for this analysis, the kinetics of methionine synthase induction were studied in the 293 cell line. As shown in Figure 1 , maximal activation is observed in -24 h, and this level is sustained up to 72 h. This is very similar to the kinetics reported in cultured BHK cells (15) . Based on these data, we compared the mRNA and protein levels at 0, 24 and 48 h following B,, addition to the cell culture medium (Figure 3) . Comparison of the ratio of methionine synthase mRNA to actin mRNA indicates that the level of the methionine synthase mRNA remains fairly constant over 48 h (Figure 4 ) during which time enzyme activity increases 2.5-fold. The two RNA bands that hybridize to the methionine synthase probe have been observed previously (9,ll) . The shorter cDNA has been sequenced completely (9) . The 10 kb band is apparently a preprocessed form of the 7.5 kb message, since it hybridizes to a probe complementary to intron 5 (11) .
Since activation of methionine synthase levels was reported to be due to conversion of apoenzyme to holoenzyme we have directly estimated the relative levels of methionine synthase protein in the presence and absence of added B,,. As seen in Figures 3B and 4 , an increase in the steady-state concentration of methionine synthase parallels the increase in its activity. It was previously reported that B,, induction of methionine synthase activity was not affected by the presence of the translation inhibitor, puromycin, added simultaneously with B,, to the cell culture medium (15) . However, these results were inconsistent with the kinetics of B,, activation in the BHK cell lines reported in the same paper, since in the presence of puromycin, full activation was observed in 12 h rather than in 24 h. Additionally, B,, has a very high affinity transport system, it is possible that the rate of B,, import was more rapid than that of puromycin, resulting in a delayed effect of puromycin. In contrast, western analysis permits a more direct evaluation of methionine synthase levels, and demonstrates unambiguously that a new protein synthesis is required for activation by B,,.
At least two alternative hypotheses can be considered to explain the mechanism of B,, induced activation of methionine synthase. First, the intracellular B,, pool increases upon supplementation of the medium and a higher proportion of newly synthesized methionine synthase is stabilized by binding cofactor. While our data do not rule this out, it seems unlikely since the levels of holoenzyme do not change significantly in most cell lines. For example 66% of methionine synthase in Cosy cells is present in the holoenzyme form regardless of whether or not the medium is supplemented with the cofactor. If stabilization of methionine synthase by an increased intracellular B,, pool resulted in the increase in its steady-state levels, the percentage of holoenzyme would have been expected to be increased.
Alternatively, methionine synthase could be translationally regulated by its cofactor. Two other folatedependent enzymes, dihydrofolate reductase and thymidylate synthase (22) (23) (24) , bind to their own mRNAs. This represses translation and represents a form of autoregulation. Binding of the nucleotide substrate (dUMP in thymidylate synthase) or cofactor (NADPH in dihydrofolate reductase) competes with binding for mRNA and alleviates translation inhibition. This has led to the suggestion that the nucleotide binding domains of RNA-binding proteins may have acquired enzymatic activity (or the converse) during evolution (25) . It is interesting to note that B,, also has a nucleotide moiety, with an unusual base, dimethylbenzimidazole, that is appended from ring D of the corrin macrocycle.
Vitamin B,, has been shown to mediate repression of gene expression in E. coli and in Salmonella typhimurium. In the latter organism, expression of the cob operon involved in the de novo biosynthesis of B,, is repressed (26) (27) (28) . In both E. coli and in S. typhimurium, B,, represses the btuB gene product encoding an outer membrane B12 transport protein (29, 30) . Studies on the mechanism of this repression reveal that it is mediated postranscriptionally (31) . A 25 bp long regulatory sequence designated as the B,, box is located -80-110 bp upstream of the initiation codon, and has been suggested to constitute the binding site of B,, itself or a B,, responsive protein (27) . In addition, a second common element observed in these transcripts is the presence of sequences in the leader with the potential to form an RNA hairpin which sequesters the RNA binding site. In the presence of B,, an RNA hairpin forms with inhibits translation initiation of the cbiA gene in S. typhimurium (28) . Since the regulatory elements for translation are distinct in prokaryotes and eukaryotes, it is not surprising that a consensus B,, box is not observed in the human methionine synthase cDNA. In summary, our data exclude both conversion of apomethionine synthase to holoenzyme and transcriptional activation as explanations for the observed induction of methionine synthase activity by its cofactor, B,,. Instead, our data demonstrate that induction of methionine synthase activity correlates with increased levels of protein, and is therefore exerted a t a posttranscriptional level. Elucidation of the mechanism of B,,-mediated posttranscriptional regulation will be the subject of future investigation.
